Molecular Diagnostics

HPV Test Approved for Primary Screening of Cervical Cancer
A newly approved molecular test offers women an alternative option for cervical cancer screening and this most recent approval means the test can now be used as the first port of call for cervical cancer screening for women aged 25 years and over. More...05 May 2014





In Other News
Blood Tests Predict Risk of Sudden Cardiac Death
Testing for Atypical Hemolytic Uremic Syndrome Goes NexGen
Imaging and Blood Test Work Together to Optimize Evaluation of Ovarian Cancer Risk
American Diagnostic Laboratory Offers Genetic Test for Calreticlin Gene Mutations
Microarray Gene Expression Approach May Help Predict Cancer Patient Survival
A Specific Mutation Links Some Forms of Inherited Melanoma
Genetic Cause Found for Rare Aggressive Ovarian Cancer
New Genetic Disease Identified in Children
New Blood Test to Provide Safe, Early Prenatal Genetic Screening
Assay Detects Tumor-Specific Gene Amplifications in ctDNA
Gene Test Predicts Melanoma Metastases
Gene Profile Predicts Risk of Bladder Cancer Recurrence
Novel DNA Test Evaluates Recurrent Pregnancy Loss
Gene Fusion Identified as Cause of Rare Thyroid Cancer
Genetic Clue to Irritable Bowel Syndrome Found
Proteomic Profiling Enables Earlier Diagnosis of Pancreatic Cancer
FDA Clears First-of-Its-kind Postnatal Test for Developmental Disabilities
New Gene Linked to Key Heart Attack Risk Factor
Fluorescent In Situ Sequencing Helps Diagnose Sick Tissues Early
Highly Specific Blood Test Detects Creutzfeldt-Jakob Disease
Preleukemic Hematopoietic Stem Cells Identified in Acute Leukemia
Combined Screening Suggested to Better Detect ALK Rearrangements in Samples from Non-Small-Cell Lung Cancer Patients
High Diagnostic Accuracy Demonstrated for New Kidney Cancer Test
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.







